(19)
(11) EP 2 569 298 A1

(12)

(43) Date of publication:
20.03.2013 Bulletin 2013/12

(21) Application number: 11719249.2

(22) Date of filing: 10.05.2011
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
C07D 413/14(2006.01)
C07D 491/10(2006.01)
C07D 471/04(2006.01)
A61K 31/506(2006.01)
A61P 37/00(2006.01)
A61P 25/00(2006.01)
C07D 405/14(2006.01)
C07D 487/04(2006.01)
C07D 495/04(2006.01)
A61K 31/4725(2006.01)
A61K 31/5377(2006.01)
A61P 9/00(2006.01)
(86) International application number:
PCT/EP2011/057545
(87) International publication number:
WO 2011/141474 (17.11.2011 Gazette 2011/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 12.05.2010 EP 10162629

(71) Applicant: Boehringer Ingelheim International GmbH
55216 Ingelheim am Rhein (DE)

(72) Inventors:
  • EBEL, Heiner
    55216 Ingelheim Am Rhein (DE)
  • FRATTINI, Sara
    55216 Ingelheim Am Rhein (DE)
  • GIOVANNINI, Riccardo
    55216 Ingelheim Am Rhein (DE)
  • HOENKE, Christoph
    55216 Ingelheim Am Rhein (DE)
  • MAZZAFERRO, Rocco
    55216 Ingelheim Am Rhein (DE)
  • SCHEUERER, Stefan
    55216 Ingelheim Am Rhein (DE)

(74) Representative: Simon, Elke Anna Maria 
Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim am Rhein
55216 Ingelheim am Rhein (DE)

   


(54) NOVEL CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS